IEQ Capital’s Precigen PGEN Stock Holding History

IEQ Capital’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,528	Closed	-$24K	–	1031
2024 Q1	$24K	Hold	16,528	–	–	﹤0.01%	961
2023 Q4	$22.1K	Hold	16,528	–	–	﹤0.01%	919
2023 Q3	$23.5K	Hold	16,528	–	–	﹤0.01%	931
2023 Q2	$19K	Hold	16,528	–	–	﹤0.01%	892
2023 Q1	$17.5K	Hold	16,528	–	–	﹤0.01%	885
2022 Q4	$25.1K	Buy	+16,528	New	+$28.4K	﹤0.01%	806

Other funds holding PGEN

PCM

Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

IEQ Capital's PGEN Position: Q2 2024 in Review

IEQ Capital sold out of Precigen (PGEN) in Q2 2024, closing a stake of 16,528 shares — an estimated $24K sold.

IEQ Capital first reported a position in PGEN in Q4 2022 and held it in 6 quarters. The position peaked at $25.1K in Q4 2022. 130 funds tracked by Wall St. Rank hold PGEN as of Q2 2024.

IEQ Capital reported no remaining Precigen position as of Q2 2024 after selling out during the quarter.
IEQ Capital sold 16,528 Precigen shares in Q2 2024, an estimated $24K.
IEQ Capital first reported a position in Precigen in Q4 2022 and held it in 6 quarters.
IEQ Capital's Precigen position peaked at $25.1K in Q4 2022.
130 funds tracked by Wall St. Rank held Precigen as of Q2 2024.

Based on IEQ Capital's 13F filing for Q2 2024, filed 12 Aug 2024.